ICVX
Icosavax, Inc.
NASDAQHealthcareBiotechnologyUS
Company Profile
CEO
Adam K. Simpson
IPO Date
2021-07-29
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Icosavax, Inc.
CEO
Adam K. Simpson
IPO Date
2021-07-29
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
| 100,000 |
| $2.47 |
| 20 Feb 2024 | Russo Thomas Joseph | other: See Remarks | D-Return | Disposed | 376,590 | $7.44 |
| 20 Feb 2024 | Russo Thomas Joseph | other: See Remarks | D-Return | Disposed | 125,000 | $9.06 |
| 20 Feb 2024 | Russo Thomas Joseph | other: See Remarks | D-Return | Disposed | 97,500 | $15.00 |
| 20 Feb 2024 | Russo Thomas Joseph | other: See Remarks | D-Return | Disposed | 74,500 | $17.55 |
| 20 Feb 2024 | FIELDS HEIDI | other: See Remarks | D-Return | Disposed | 2,917 | $0.00 |
| 20 Feb 2024 | FIELDS HEIDI | other: See Remarks | U-Tender | Disposed | 11,376 | $15.00 |
| 20 Feb 2024 | FIELDS HEIDI | other: See Remarks | D-Return | Disposed | 22,278 | $6.25 |
| 20 Feb 2024 | FIELDS HEIDI | other: See Remarks | D-Return | Disposed | 25,266 | $7.44 |